DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Bevenopran
Bevenopran
Classification Decisions Taken by the Harmonized System Committee from the 47Th to 60Th Sessions (2011
Stems for Nonproprietary Drug Names
Functional Bowel Disorders
Lääkeaineiden Yleisnimet (INN-Nimet) 21.6.2021
Efficacy of Pharmacological Therapies for the Treatment of Opioid-Induced Constipation: Systematic Review and Network Meta-Analysis
A Abacavir Abacavirum Abakaviiri Abagovomab Abagovomabum
Exploring Relief and Managing Side Effects of This Activity Issupported Byan Educationalgrant from Astrazeneca
( 19 ) United States
(2006.01) A61P 25/36 (2006.01) A61K 9/00 (2006.01) (21) International Application Number: PCT/US20 19/059852 (22) International Filing Date: 05 November 2019 (05
Peripherally Acting Mu-Opioid Antagonist for the Treatment of Opioid-Induced
Opioid-Induced Constipation - Opportunity Analysis and Forecasts to 2017
WO 2018/005695 Al O
Peripherally Acting Μ‐Opioid Antagonist for the Treatment Of
Definition, Diagnosis and Treatment Strategies for Opioid-Induced Bowel
(PDF) Download
Il Problema Della Stipsi Nel Paziente Anziano Oncologico in Trattamento Con Oppiacei
En Busca Del Opioide Ideal. Nuevas Moléculas
International Nonproprietary Names for Pharmaceutical Substances (INN)
Top View
Stop the (Mu)Sic (Gregory)
Bevenopran Fact Sheet
Neuronal Signaling
Naloxegol for Treating Opioid-Induced Constipation
A61p25/06 (2006.01) A61p25/22 (2006.01)
Naloxegol an Investigational Drug for the Treatment of Opioid -Induced Constipation
Opioid-Induced Constipation (In Non-Cancer Pain)
INN-Nimet 1 20.8.2019 a Abacavir Abacavirum Abakaviiri
Machine Learning Harnesses Molecular Dynamics to Discover New Μ Opioid Chemotypes